Matches in SemOpenAlex for { <https://semopenalex.org/work/W2331330116> ?p ?o ?g. }
Showing items 1 to 50 of
50
with 100 items per page.
- W2331330116 abstract "Well known, well detected and still used by athletes, clenbuterol is one of the β 2 -agonists which has no authorization for therapeutic use, contrarily to salbutamol, salmeterol and formoterol in the 2012 World Anti-Doping Agency list. However, clenbuterol is still detected in athletes’ antidoping test samples. Its ability to induce muscle hypertrophy but also its strong lipolytic action and the absence of androgenic effects have made it a prized substances by athletes, specially females, without scruples whose performance requires significant muscle strength. Like the effects of clenbuterol on the heart, the effects of clenbuterol on skeletal muscle are dependent on the doses used and duration of the treatment. If there is a consensus concerning the clenbuterol action on the phenotypic conversion from slow to fast type fibers and on the hypertrophy, there is, to our knowledge, no consensus concerning the effects of clenbuterol on the slow type fibers and slow profile muscles. There is also no consensus concerning the clenbuterol effects on performance. We will shortly reviewing the known operating mode, side and benefits effects of short and long term β-agonists, and specially clenbuterol, treatment on mammals" @default.
- W2331330116 created "2016-06-24" @default.
- W2331330116 creator A5031339229 @default.
- W2331330116 date "2012-01-01" @default.
- W2331330116 modified "2023-10-01" @default.
- W2331330116 title "Skeletal and Cardiac Muscle Ergogenics and Side Effects of Clenbuterol Treatment" @default.
- W2331330116 doi "https://doi.org/10.4172/2161-0673.s1-001" @default.
- W2331330116 hasPublicationYear "2012" @default.
- W2331330116 type Work @default.
- W2331330116 sameAs 2331330116 @default.
- W2331330116 citedByCount "1" @default.
- W2331330116 countsByYear W23313301162014 @default.
- W2331330116 crossrefType "journal-article" @default.
- W2331330116 hasAuthorship W2331330116A5031339229 @default.
- W2331330116 hasBestOaLocation W23313301161 @default.
- W2331330116 hasConcept C126322002 @default.
- W2331330116 hasConcept C2776327530 @default.
- W2331330116 hasConcept C2779959927 @default.
- W2331330116 hasConcept C41008148 @default.
- W2331330116 hasConcept C60644358 @default.
- W2331330116 hasConcept C71924100 @default.
- W2331330116 hasConcept C86803240 @default.
- W2331330116 hasConcept C98274493 @default.
- W2331330116 hasConceptScore W2331330116C126322002 @default.
- W2331330116 hasConceptScore W2331330116C2776327530 @default.
- W2331330116 hasConceptScore W2331330116C2779959927 @default.
- W2331330116 hasConceptScore W2331330116C41008148 @default.
- W2331330116 hasConceptScore W2331330116C60644358 @default.
- W2331330116 hasConceptScore W2331330116C71924100 @default.
- W2331330116 hasConceptScore W2331330116C86803240 @default.
- W2331330116 hasConceptScore W2331330116C98274493 @default.
- W2331330116 hasIssue "01" @default.
- W2331330116 hasLocation W23313301161 @default.
- W2331330116 hasOpenAccess W2331330116 @default.
- W2331330116 hasPrimaryLocation W23313301161 @default.
- W2331330116 hasRelatedWork W2029238298 @default.
- W2331330116 hasRelatedWork W2051153068 @default.
- W2331330116 hasRelatedWork W2095078229 @default.
- W2331330116 hasRelatedWork W2123127974 @default.
- W2331330116 hasRelatedWork W21359900 @default.
- W2331330116 hasRelatedWork W2400148842 @default.
- W2331330116 hasRelatedWork W2748952813 @default.
- W2331330116 hasRelatedWork W2753716956 @default.
- W2331330116 hasRelatedWork W2899084033 @default.
- W2331330116 hasRelatedWork W2395696633 @default.
- W2331330116 hasVolume "S1" @default.
- W2331330116 isParatext "false" @default.
- W2331330116 isRetracted "false" @default.
- W2331330116 magId "2331330116" @default.
- W2331330116 workType "article" @default.